Signal Peptide Database - Drosophila melanogaster

 Entry Details
ID   25702
Source Database   UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number   P15215    (Created: 1990-04-01 Updated: 2008-12-16)
UniProtKB/Swiss-Prot Entry Name   LAMC1_DROME
Protein Name   Laminin subunit gamma-1
Gene   LanB2
Organism Scientific   Drosophila melanogaster
Organism Common   Fruit fly
Lineage   Eukaryota
  Metazoa
    Arthropoda
      Hexapoda
        Insecta
          Pterygota
            Neoptera
              Endopterygota
                Diptera
                  Brachycera
                    Muscomorpha
                      Ephydroidea
                        Drosophilidae
                          Drosophila
                            Sophophora
Protein Length [aa]   1639
Protein Mass [Da]   182339
Features  
TypeDescriptionStatusStartEnd
signal peptide      potential   1   33
chain   Laminin subunit gamma-1      34   1639
disulfide bond      by similarity   299   308
disulfide bond      by similarity   301   322
disulfide bond      by similarity   324   333
disulfide bond      by similarity   336   356
disulfide bond      by similarity   359   368
disulfide bond      by similarity   361   384
disulfide bond      by similarity   387   396
disulfide bond      by similarity   399   411
disulfide bond      by similarity   414   426
disulfide bond      by similarity   416   432
disulfide bond      by similarity   434   443
disulfide bond      by similarity   446   458
disulfide bond      by similarity   461   475
disulfide bond      by similarity   463   482
disulfide bond      by similarity   484   493
disulfide bond      by similarity   496   511
disulfide bond      by similarity   712   721
disulfide bond      by similarity   724   741
disulfide bond      by similarity   744   753
disulfide bond      by similarity   746   760
disulfide bond      by similarity   762   771
disulfide bond      by similarity   774   790
disulfide bond      by similarity   793   801
disulfide bond      by similarity   795   811
disulfide bond      by similarity   814   823
disulfide bond      by similarity   826   844
disulfide bond      by similarity   847   861
disulfide bond      by similarity   849   868
disulfide bond      by similarity   871   880
disulfide bond      by similarity   883   899
disulfide bond      by similarity   902   919
disulfide bond      by similarity   904   926
disulfide bond      by similarity   928   937
disulfide bond      by similarity   940   953
disulfide bond      by similarity   956   968
disulfide bond      by similarity   958   975
disulfide bond      by similarity   977   986
disulfide bond      by similarity   989   1001
disulfide bond      by similarity   1004   1016
disulfide bond      by similarity   1006   1022
disulfide bond      by similarity   1024   1033
disulfide bond      by similarity   1036   1047
disulfide bond   Interchain   probable   1050   1050
disulfide bond   Interchain   probable   1053   1053
disulfide bond   Interchain   probable   1631   1631
domain   Laminin N-terminal      63   298
domain   Laminin EGF-like 1      299   358
domain   Laminin EGF-like 2      359   413
domain   Laminin EGF-like 3      414   460
domain   Laminin EGF-like 4      461   513
domain   Laminin EGF-like 5; first part      514   523
domain   Laminin IV type A      533   709
domain   Laminin EGF-like 5; second part      710   743
domain   Laminin EGF-like 6      744   792
domain   Laminin EGF-like 7      793   846
domain   Laminin EGF-like 8      847   901
domain   Laminin EGF-like 9      902   955
domain   Laminin EGF-like 10      956   1003
domain   Laminin EGF-like 11      1004   1049
region of interest   Domain II and I      1050   1609
glycosylation site   N-linked (GlcNAc...)   potential   147   147
glycosylation site   N-linked (GlcNAc...)   potential   376   376
glycosylation site   N-linked (GlcNAc...)   potential   669   669
glycosylation site   N-linked (GlcNAc...)   potential   862   862
glycosylation site   N-linked (GlcNAc...)   potential   965   965
glycosylation site   N-linked (GlcNAc...)   potential   1070   1070
glycosylation site   N-linked (GlcNAc...)   potential   1156   1156
glycosylation site   N-linked (GlcNAc...)   potential   1394   1394
glycosylation site   N-linked (GlcNAc...)   potential   1479   1479
glycosylation site   N-linked (GlcNAc...)   potential   1584   1584
sequence variant         0   0
sequence variant   (in strain: Oregon-R)      0   0
coiled-coil region      potential   1087   1109
coiled-coil region      potential   1144   1247
coiled-coil region      potential   1306   1627
SP Length   33
 ----+----1----+----2----+----3----+----4----+----5
Signal Peptide MKRSRWSHSGSSTARLLLIGVLFASCSTAILGA
Sequence MKRSRWSHSGSSTARLLLIGVLFASCSTAILGAQRPPINSAGGHELRGTT
FMPALECYDPYG
RPQKCLPEFINAAYQLQIESTNTCGEQNDNHFCIQTMN
QNHKNCEFCKYNDHNPSFLTDLHDPQSPTWWQSETMFEGIQHPNYV
NLTL
HLGKSYDITYVRILFRSPRPESFTIYKRTSESGPWIPYQFYSATCRDTYS
LPDSRAIRKGEGEAHALCTSEYSDISPLRDGEIAFSTLEGRPSGINFERS
GELQEWVTATDIRITLDRLNTFGDELFGDSQVLKSYFYAISDIAVGAR
CK
CNGHASKCVPSTGMHGERTLVCECRHNTDGPDCDRCLPLYNDLKWKRSTS
TEVNECKA
CNCNGLADKCFFDANLFNRTGHGGHCLDCRENRDGPNCERCK
ENFYMRDDGYCVN
CACDPVGSRSLQCNSHGKCQCKPGVTGDKCDRCDNNY
YQFGPHGCQQ
CGCDSGGSHQNTPACDTETGICFCKENVEGRRCNECKPGF
FNLDKNNRFGCTP
CFCYGHTSECMTAPGYSIVSVTSNFNKFKERWTAADL
NQREVDIKYNQYSRSIGTTAQGNEHVYFQAPDRFLGDQRASYNRDLKFKL
QLVGQVANTGVSDVILEGAGSRISLPIFAQGNGIPDQGVKEYTFRLHEHH
DYQWQPSQSARGFLSILS
NLTAIKIRATYSVQGEAILDDVELQTAHRGAA
GHPATWIEQ
CTCPEGYLGQFCESCAPGYRHSPARGGPFMPCIPCDCHGHA
DICDSETGRCICQHNTHGDNCDQCAKGFYGNALGGTPNDCKR
CPCPNDGA
CLQINEDTVICTECPKGYFGSRCEQCSDGFFGDPTGLLGEVQTCKS
CDCN
GNVDPNAVGNC
NRTTGECLKCIHNTAGEHCDQCLSGHFGDPLALPHGRCD
R
CSCYEAGTEQDEQSITRCDQVTGQCQCKPNVIGRDCGECQPGYFNIRSG
NGCEN
CLCDPVGSYNSTCDRYSGQCHCRPGVMGQRCDQCENYFYGFSSEG
CKP
CECDESGSKGFQCDQNGQCPCNDNVEGRRCDRCKENKYDRHRGCIDC
PDCYNLVQDAADLHRAKLF
NLSQTLDEIARTPVTNDDEFEAKLKAVQEKV
AVLAQDARD
NSGDGGQTYAEVIDDLHKHLDSVREHLVSADKFQADANGEI
DRARQNYTILDQITENAKKELQQALDLLNDEGAQALARAKEKSVEFGQQS
EQISDISREARALADKLESEAQFDLKNAKDAKDAVEKAHQLAKSAID
LQL
KIGTELRSEVGLELSHVKQSLGTVVQTSKEALRKANEVYDTALTLLNDVN
RQTQP
EIDISQLKKDAVAANERADELLKQITELSNSNGELFADFETEQEL
TEALLKRAEQQQLEDIELLERAKAAHDKATKAVEQGDNTLKEANNTYEKL
AGFQSDVQRSSESAEKALQTVPNIEKEIQNAESLISQAEEALDGANKNAN
EAKKNAQEAQLKYAEQASKDAELIRRKANETKVAARNLREEADQLNHRVK
LTEMDIFKLEESSTKDDNLVDDAKRKVGQAKADTQEAQKQIEKANADLTA
IKDELENLKDINTGDLDRLENRLATVEGEINRVNLTGRIEKYREQRTIQK
NLIDKYDAELRELKDEVQNIGLISKAL
PDSCFSRNRLEP
Original MKRSRWSHSGSSTARLLLIGVLFASCSTAILGAQRPPINSAGGHELRGTT
FMPALECYDPYGRPQKCLPEFINAAYQLQIESTNTCGEQNDNHFCIQTMN
QNHKNCEFCKYNDHNPSFLTDLHDPQSPTWWQSETMFEGIQHPNYVNLTL
HLGKSYDITYVRILFRSPRPESFTIYKRTSESGPWIPYQFYSATCRDTYS
LPDSRAIRKGEGEAHALCTSEYSDISPLRDGEIAFSTLEGRPSGINFERS
GELQEWVTATDIRITLDRLNTFGDELFGDSQVLKSYFYAISDIAVGARCK
CNGHASKCVPSTGMHGERTLVCECRHNTDGPDCDRCLPLYNDLKWKRSTS
TEVNECKACNCNGLADKCFFDANLFNRTGHGGHCLDCRENRDGPNCERCK
ENFYMRDDGYCVNCACDPVGSRSLQCNSHGKCQCKPGVTGDKCDRCDNNY
YQFGPHGCQQCGCDSGGSHQNTPACDTETGICFCKENVEGRRCNECKPGF
FNLDKNNRFGCTPCFCYGHTSECMTAPGYSIVSVTSNFNKFKERWTAADL
NQREVDIKYNQYSRSIGTTAQGNEHVYFQAPDRFLGDQRASYNRDLKFKL
QLVGQVANTGVSDVILEGAGSRISLPIFAQGNGIPDQGVKEYTFRLHEHH
DYQWQPSQSARGFLSILSNLTAIKIRATYSVQGEAILDDVELQTAHRGAA
GHPATWIEQCTCPEGYLGQFCESCAPGYRHSPARGGPFMPCIPCDCHGHA
DICDSETGRCICQHNTHGDNCDQCAKGFYGNALGGTPNDCKRCPCPNDGA
CLQINEDTVICTECPKGYFGSRCEQCSDGFFGDPTGLLGEVQTCKSCDCN
GNVDPNAVGNCNRTTGECLKCIHNTAGEHCDQCLSGHFGDPLALPHGRCD
RCSCYEAGTEQDEQSITRCDQVTGQCQCKPNVIGRDCGECQPGYFNIRSG
NGCENCLCDPVGSYNSTCDRYSGQCHCRPGVMGQRCDQCENYFYGFSSEG
CKPCECDESGSKGFQCDQNGQCPCNDNVEGRRCDRCKENKYDRHRGCIDC
PDCYNLVQDAADLHRAKLFNLSQTLDEIARTPVTNDDEFEAKLKAVQEKV
AVLAQDARDNSGDGGQTYAEVIDDLHKHLDSVREHLVSADKFQADANGEI
DRARQNYTILDQITENAKKELQQALDLLNDEGAQALARAKEKSVEFGQQS
EQISDISREARALADKLESEAQFDLKNAKDAKDAVEKAHQLAKSAIDLQL
KIGTELRSEVGLELSHVKQSLGTVVQTSKEALRKANEVYDTALTLLNDVN
RQTQPEIDISQLKKDAVAANERADELLKQITELSNSNGELFADFETEQEL
TEALLKRAEQQQLEDIELLERAKAAHDKATKAVEQGDNTLKEANNTYEKL
AGFQSDVQRSSESAEKALQTVPNIEKEIQNAESLISQAEEALDGANKNAN
EAKKNAQEAQLKYAEQASKDAELIRRKANETKVAARNLREEADQLNHRVK
LTEMDIFKLEESSTKDDNLVDDAKRKVGQAKADTQEAQKQIEKANADLTA
IKDELENLKDINTGDLDRLENRLATVEGEINRVNLTGRIEKYREQRTIQK
NLIDKYDAELRELKDEVQNIGLISKALPDSCFSRNRLEP
 ----+----1----+----2----+----3----+----4----+----5
Hydropathies  
 

© 2007-2017 Dr. Katja Kapp, Kassel & thpr.net e. K., Dresden, Germany, last update 2010-06-11